"clinical trial"

“The continent should take the matter of resistance very, very seriously...Resistance should be seen as an emergency situation.”

The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.

The real story is that we're approaching the ability to read, interpret and eventually intervene in the human body's operating system.

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, offering a mor...

A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients

Neuroscience research connects dopamine, spontaneity, movement disorders, probabilistic behavior, and AI-driven brain understanding advances...

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tu...

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV vaccine may fin...

Hegeth's new testosterone initiative is meant to strengthen the military. Is it without risks?

Distrust in medicine and science isn't a new crisis. Drawing on decades in communities, a physician explains the real source and how we earn...

In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a week, how new s...